Search

everythinglearnresearchcommunity

for

Search:↓

Blackcurrant extract may help reduce hair loss by promoting stem cell activity in hair follicles.

Increased scalp sweating in frontal fibrosing alopecia may be linked to local skin inflammation.

Women with early-onset baldness should be checked for early bone loss, but bone density doesn't change with baldness severity.

The treatment reduced hair growth and testosterone in women with excess hair and had some effects on stress responses.

Many elderly women experience unwanted facial hair and various hair loss conditions, with treatments available for each condition.

Women with high androgen levels may have more severe COVID-19 symptoms.

Testosterone therapy may slightly improve sexual function in postmenopausal women, but its long-term safety is unknown.

Many infertile women with PCOS in Central Vietnam have metabolic or insulin resistance syndrome, with obesity and older age increasing the risk.

Middle-aged women with PCOS often continue to experience symptoms related to high androgen levels, like unwanted hair growth.

Women may need different blood pressure guidelines than men for heart disease prevention.

Finasteride doesn't effectively treat hair loss in postmenopausal women.

Hyperandrogenism increases heart disease risk in premenopausal women, but this risk is linked to obesity in postmenopausal women.

PCOS is diagnosed when at least two of these three features are present: polycystic ovaries, irregular ovulation, and high androgen levels.

PCOS is managed by lifestyle changes and personalized medication to improve symptoms and fertility.

The document concludes that hormonal biomarkers are key for diagnosing hyperandrogenemia in women and hypogonadism in men.

Women with nonclassic congenital adrenal hyperplasia experience more sexual dysfunction and distress.

Premature ovarian insufficiency (POI) can harm women's sexual health, and they may benefit from hormone therapy and counseling.

Women with PCOS have similar bone density to healthy women, but those who are obese have higher bone density at some body sites.

Iron deficiency in menstruating women causes many health issues beyond anemia and needs early detection and treatment.

Women with irregular periods have a higher risk of heart disease.

Ovarian hyperthecosis should be considered in young women with severe male-like symptoms and can be managed with hormone treatments.

The document concludes that proper diagnosis and individualized treatment are crucial for managing androgenization in women effectively.

The document concludes that diagnosing PCOS requires a thorough approach, considering various symptoms and risks, and calls for improved methods to identify PCOS types and prevent diabetes.

FFA is more common in postmenopausal women, can affect younger women, and may stabilize over time.

Women with PCOS may have a higher risk of respiratory and ear infections due to slower nasal mucociliary clearance.

Women with PCOS have thicker parafoveal areas in their retinas, but their macular blood vessel density is normal.

Women's ovarian hormones and adrenal androgens change throughout life, affecting hair loss and health.

The conclusion is that managing cholesterol is important for women, especially during pregnancy, breastfeeding, and with PCOS, and involves regular screening and careful treatment choices.

Hormonal therapies like cyproterone acetate and spironolactone may help some women with hair loss, but finasteride 1mg is not useful, and the effectiveness of other treatments is still unclear.

Testosterone therapy seems safe for short-term use in postmenopausal women with low sexual desire, but more research on long-term effects is needed.